ESC 365 - Glucose lowering agents in the Prevention of Cardiovascular events and Mortality in Type II Diabetes.

ESC Premium Access

Glucose lowering agents in the Prevention of Cardiovascular events and Mortality in Type II Diabetes.

Session: Prevention 360: Strategies for Managing Cardiovascular Risk

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Doctor V. Menon (Cleveland, US)

Sponsored by Cleveland Clinic

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Venu Menon

Cleveland Clinic, Cleveland (United States of America)

9 presentations

1 follower

3 more presentations in this session

What is optimal BP? Key differences and controversies among the many guidelines.

Speaker: Doctor L. Cho (Cleveland, US)

Therapeutic Options Targeting Residual CVD Risk: Current Therapies for the Treatment of Dyslipidemia.

Speaker: Professor S. Nicholls (Melbourne, AU)

Pharmacotherapy Options for Obesity and Cardiometabolic Risk: Helpful or Harmful?

Speaker: Professor S. Nissen (Cleveland, US)

Access the full session

Prevention 360: Strategies for Managing Cardiovascular Risk

Speakers: Doctor V. Menon, Doctor L. Cho, Professor S. Nicholls, Professor S. Nissen

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources